Idiopathic retroperitoneal fibrosis: an update for nephrologists

V Raglianti, GM Rossi, A Vaglio - Nephrology Dialysis …, 2021 - academic.oup.com
Idiopathic retroperitoneal fibrosis (IRF) is a rare condition characterized by the development
of a peri-aortic and peri-iliac tissue showing chronic inflammatory infiltrates and pronounced …

Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis

P Fenaroli, F Maritati, A Vaglio - Current Rheumatology Reports, 2021 - Springer
Abstract Purpose of the Review We aim to review the most relevant diagnostic features and
treatment options of retroperitoneal fibrosis, in order to provide a useful guide for clinical …

[HTML][HTML] End-stage renal disease

MF Hashmi, O Benjamin, SL Lappin - 2018 - europepmc.org
Objectives: Describe the causes of end-stage renal disease. Outline the presentation of a
patient with end-stage renal disease. Summarize the treatment options for end-stage renal …

Renal involvement in IgG4-related disease: from sunlight to twilight

R Capecchi, D Giannese, D Moriconi… - Frontiers in …, 2021 - frontiersin.org
IgG4-Related Disease (IgG4-RD) is a fibroinflammatory condition characterized by a typical
histopathological pattern (dense lymphoplasmacytic infiltrate with prevalent IgG4+ plasma …

Renal involvement in retroperitoneal fibrosis: prevalence, impact and management challenges

I Mizushima, M Kawano - International Journal of Nephrology and …, 2021 - Taylor & Francis
Retroperitoneal fibrosis (RPF) is a rare disorder consisting of idiopathic and various
secondary forms and characterized by chronic inflammatory infiltrates and marked fibrosis in …

Retroperitoneal fibrosis and its differential diagnoses: the role of radiological imaging

F Peisen, WM Thaiss, K Ekert, M Horger… - RöFo-Fortschritte auf …, 2020 - thieme-connect.com
Hintergrund Die retroperitoneale Fibrose ist mit einer Inzidenz von 0–1/100 000
Einwohner/Jahr eine seltene Erkrankung, welche mit einer chronisch-entzündlichen …

Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function?

D Giannese, D Moriconi, A Cupisti, A Zucchi… - Urologia …, 2023 - karger.com
Background: The aim of this study was to investigate the long-term effects of ureteral stenting
and the exact timing of stent removal in favor of surgery in patients with idiopathic …

[HTML][HTML] Retroperitoneal fibrosis

JS Engelsgjerd, SW Leslie, CA LaGrange - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify patients with possible retroperitoneal fibrosis based on their clinical
history and presentation. Implement a comprehensive diagnostic approach that includes …

Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis

H Gao, S Liu, Y Mai, Y Wang, X Zhang… - Annals of the …, 2023 - ard.bmj.com
Objectives Retroperitoneal fibrosis (RPF) is a rare autoimmune disease with fibrous tissue
growth and inflammation in retroperitoneum. Its current treatments involve long-term uptake …

Outcomes of retroperitoneal fibrosis-related hydronephrosis and its risk factors for poor prognosis: a multi-center retrospective cohort study in Chinese patients

H Liu, H Gao, J Zhao, U Wong, S Liu, J Liu… - Frontiers in …, 2024 - frontiersin.org
Objective Retroperitoneal fibrosis (RPF) is a rare disease characterized by the presence of
fibroinflammatory tissue that surrounds the abdominal aorta and the iliac arteries and often …